Innospec Inc. (IOSP)
NASDAQ: IOSP · Real-Time Price · USD
76.78
+0.52 (0.68%)
May 1, 2026, 1:14 PM EDT - Market open
Innospec Employees
Innospec had 2,450 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2,450
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$725,714
Profits / Employee
$47,592
Market Cap
1.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,450 | 0 | - |
| Dec 31, 2024 | 2,450 | 50 | 2.08% |
| Dec 31, 2023 | 2,400 | 300 | 14.29% |
| Dec 31, 2022 | 2,100 | 200 | 10.53% |
| Dec 31, 2021 | 1,900 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Avient | 9,000 |
| H.B. Fuller Company | 7,100 |
| Quaker Chemical | 4,700 |
| Minerals Technologies | 3,782 |
| Ashland | 2,900 |
| Stepan Company | 2,328 |
| Calumet | 1,540 |
| Ingevity | 1,500 |
IOSP News
- 2 months ago - Innospec Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Innospec Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Innospec Fuel Specialties Announces New Partnership With Africa Gifted Foundation to Advance Stem Education for Young Women - GlobeNewsWire
- 3 months ago - Innospec Schedules Fourth Quarter 2025 Earnings Release and Conference Call - GlobeNewsWire
- 6 months ago - Innospec Earnings Call Transcript: Q3 2025 - Transcripts
- 7 months ago - Innospec Schedules Third Quarter 2025 Earnings Release and Conference Call - GlobeNewsWire
- 8 months ago - Innospec and International Justice Mission (IJM) Enter Second Year of Partnership to Protect Palm Oil Workers in Indonesia - GlobeNewsWire
- 9 months ago - Innospec Earnings Call Transcript: Q2 2025 - Transcripts